Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure

Ayesha I De Souza1, Sophie Cardin, Robin Wait

  • 1Department of Cardiac & Vascular Sciences, St. George's University of London, London, UK. adesouza@sgul.ac.uk

Insights

Congestive heart failure (CHF) causes significant atrial changes. Proteomic and metabolomic analyses reveal time-dependent alterations in structural proteins, oxidant stress, and energy metabolism, contributing to atrial remodeling and fibrillation risk.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Congestive heart failure (CHF) is linked to atrial structural remodeling and increased atrial fibrillation susceptibility.
  • The precise molecular mechanisms driving these changes remain incompletely understood.

Purpose of the Study:

  • To investigate time-dependent proteomic and metabolomic alterations in the left atrium during ventricular-tachypaced (VTP)-induced CHF.
  • To elucidate molecular mechanisms underlying atrial remodeling and increased arrhythmia risk in CHF.

Main Methods:

  • High-throughput proteomic analysis (2D gel electrophoresis, tandem mass spectrometry) of left-atrial tissues from sham and VTP-induced CHF dogs.
  • Metabolomic analysis using high-resolution NMR spectroscopy.
  • Confirmation of structural damage via electron microscopy.

Main Results:

  • Significant changes in structural proteins (desmin, filamin fragmentation) and decreased antioxidant proteins (superoxide dismutase, peroxiredoxin) at 2-week VTP.
  • Dynamic changes in cardioprotective heat shock proteins (HSPs) and enzymes involved in energy metabolism, indicating an adaptive response to stress.
  • Metabolomic shifts including increased glucose and alanine, ADP/ATP accumulation, and alpha-ketoisovalerate depletion, suggesting metabolic stress and altered energy utilization.

Conclusions:

  • Ventricular-tachypacing-induced CHF leads to time-dependent alterations in the atrial proteome and metabolome.
  • These molecular changes provide critical insights into the mechanisms of arrhythmogenic atrial remodeling in CHF.
  • Findings highlight the complex interplay of structural damage, oxidative stress, and metabolic dysregulation in CHF-associated atrial fibrillation.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...